4SC AG

Biotechnology

Products/services: 4SC AG is a clinical-stage biopharmaceutical company developing small-molecule drugs that can target key indications in cancer with high unmet medical needs. 4SC’s pipeline is protected by a comprehensive portfolio of patents and currently comprises two drug candidates in clinical development: resminostat and domatinostat. 4SC aims to generate future growth and enhance its enterprise value by entering into partnerships with pharmaceutical and biotech companies and/or the eventual marketing and sales of approved drugs in select territories by 4SC itself. 4SC is headquartered in Planegg-Martinsried near Munich, Germany. The Company had 47 employees as of 30 June 2019 and is listed on the Prime Standard of the Frankfurt Stock Exchange (FSE Prime Standard: VSC; ISIN: DE000A14KL72). 4SC AG is a clinical-stage biopharmaceutical company developing small-molecule drugs that can target key indications in cancer with high unmet medical needs. 4SC’s pipeline is protected by a comprehensive portfolio of patents and currently comprises two drug candidates in clinical development: resminostat and domatinostat. 4SC aims to generate future growth and enhance its enterprise value by entering into partnerships with pharmaceutical and biotech companies and/or the eventual marketing and sales of approved drugs in select territories by 4SC itself. 4SC is headquartered in Planegg-Martinsried near Munich, Germany. The... read more 

    • Short facts
      • Research & Development
    • Year founded 1997
    • 47 Employees (site)
    • Turnover: <5m EUR
    Company
    4SC AG
    Street
    Frauenhoferstr. 22
    PC/City
    82152 Planegg-Martinsried
    County
    München / Upper Bavaria
    Phone
    +49 89 700763-0
    Fax
    +49 89 700763-29
    Email
    public@4sc.com
    Homepage
    http://www.4sc.de
    Language skills
    English, German
    Contact person
    Management: Dr. Jason Loveridge (Mr.)
    Location Map
    Key to Bavaria Map
  • Core competencies

    not available

    Key sectors / sub-sectors
    • Biotechnology: Bioinformatics and cheminformatics
    • Biotechnology: Preclinical development
    • Biotechnology: Therapeutic drug development
    NACE industries
    • Manufacture of basic pharmaceutical products and pharmaceutical preparations 21
    • Manufacture of pharmaceutical preparations 21.2
    • Manufacture of pharmaceutical preparations 21.20
    • Scientific research and development 72
    Certifications / awards

    not available

    Sales markets - target industries
    not available
    Sales markets - target countries
    not available
    Cooperation offers
    not available